- Home
- CBLL vs FINS Comparison
CBLL vs FINS Comparison
Compare CBLL & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBLL
- FINS
- Stock Information
- Founded
- CBLL 2014
- FINS 2019
- Country
- CBLL United States
- FINS United States
- Employees
- CBLL N/A
- FINS N/A
- Industry
- CBLL
- FINS Finance/Investors Services
- Sector
- CBLL
- FINS Finance
- Exchange
- CBLL Nasdaq
- FINS Nasdaq
- Market Cap
- CBLL 428.8M
- FINS 447.8M
- IPO Year
- CBLL 2024
- FINS N/A
- Fundamental
- Price
- CBLL $12.88
- FINS $12.97
- Analyst Decision
- CBLL Strong Buy
- FINS
- Analyst Count
- CBLL 5
- FINS 0
- Target Price
- CBLL $24.20
- FINS N/A
- AVG Volume (30 Days)
- CBLL 326.4K
- FINS 78.0K
- Earning Date
- CBLL 11-04-2025
- FINS 01-01-0001
- Dividend Yield
- CBLL N/A
- FINS 9.97%
- EPS Growth
- CBLL N/A
- FINS N/A
- EPS
- CBLL N/A
- FINS N/A
- Revenue
- CBLL $82,813,000.00
- FINS N/A
- Revenue This Year
- CBLL $35.50
- FINS N/A
- Revenue Next Year
- CBLL $28.24
- FINS N/A
- P/E Ratio
- CBLL N/A
- FINS N/A
- Revenue Growth
- CBLL 37.93
- FINS N/A
- 52 Week Low
- CBLL $10.01
- FINS $11.61
- 52 Week High
- CBLL $32.75
- FINS $12.57
- Technical
- Relative Strength Index (RSI)
- CBLL 56.66
- FINS 41.11
- Support Level
- CBLL $12.36
- FINS $13.05
- Resistance Level
- CBLL $13.15
- FINS $13.28
- Average True Range (ATR)
- CBLL 0.63
- FINS 0.11
- MACD
- CBLL 0.12
- FINS -0.01
- Stochastic Oscillator
- CBLL 88.26
- FINS 11.71
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.